Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSI
1826
DELISTED
Vitamin Shoppe Inc.
VSI
| $3.73M | 0.01% |
696,307
+632,429
| +990% | +$4.88M |
|
1827
Lindsay Corp
LNN
$1.16B
| $3.72M | 0.01% |
+40,507
| New | +$3.61M |
|
1828
PUT
ICU Medical
ICUI
$4.49B
| $3.72M | 0.01% |
+20,000
| New | +$3.49M |
|
1829
Whirlpool
WHR
$2.62B
| $3.71M | 0.01% |
20,086
-49,122
| -71% | -$8.78M |
|
1830
TAL Education Group
TAL
$6.48B
| $3.69M | 0.01% |
+109,593
| New | +$3.09M |
|
|
LDL
1831
DELISTED
Lydall, Inc.
LDL
| $3.69M | 0.01% |
64,419
+28,513
| +79% | +$1.42M |
|
1832
Adient
ADNT
$1.46B
| $3.67M | 0.01% |
43,737
+19,537
| +81% | +$1.39M |
|
1833
State Street Utilities Select Sector SPDR ETF
XLU
$22.3B
| $3.66M | 0.01% |
137,888
-154,636
| -53% | -$4.15M |
|
1834
Central Garden & Pet Co Class A
CENTA
$2.39B
| $3.65M | 0.01% |
122,720
-113,053
| -48% | -$3M |
|
|
ACGN
1835
DELISTED
Aceragen Inc
ACGN
| $3.64M | 0.01% |
12,024
+8,232
| +217% | +$2.15M |
|
1836
iShares MSCI Taiwan ETF
EWT
$11.5B
| $3.63M | 0.01% |
+100,560
| New | +$3.69M |
|
|
RICE
1837
DELISTED
Rice Energy Inc.
RICE
| $3.62M | 0.01% |
125,001
-349,621
| -74% | -$9.55M |
|
|
EMKR
1838
DELISTED
Emcore Corp
EMKR
| $3.62M | 0.01% |
44,084
+23,000
| +109% | +$2.23M |
|
|
HIBB
1839
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $3.61M | 0.01% |
253,068
-216,577
| -46% | -$3.21M |
|
|
TSS
1840
CALL
DELISTED
Total System Services, Inc.
TSS
| $3.6M | 0.01% |
+55,000
| New | +$3.56M |
|
1841
Citi Trends
CTRN
$576M
| $3.6M | 0.01% |
181,193
+139,749
| +337% | +$2.77M |
|
1842
CALL
Puma Biotechnology
PBYI
$473M
| $3.59M | 0.01% |
+30,000
| New | +$2.79M |
|
1843
PUT
Fortinet
FTNT
$116B
| $3.58M | 0.01% |
+500,000
| New | +$3.8M |
|
1844
Assembly Biosciences
ASMB
$721M
| $3.58M | 0.01% |
8,539
-3,600
| -30% | -$1.1M |
|
1845
iShares Russell 1000 ETF
IWB
$48.9B
| $3.58M | 0.01% |
25,575
+2,207
| +9% | +$303K |
|
|
CSW
1846
CSW Industrials
CSW
$5.26B
| $3.58M | 0.01% |
80,641
+67,035
| +493% | +$2.72M |
|
1847
Vistra
VST
$47B
| $3.57M | 0.01% |
190,951
+148,106
| +346% | +$2.55M |
|
|
VWR
1848
DELISTED
VWR Corporation
VWR
| $3.56M | 0.01% |
107,393
-51,277
| -32% | -$1.69M |
|
|
KBAL
1849
DELISTED
Kimball International
KBAL
| $3.56M | 0.01% |
179,836
+135,960
| +310% | +$2.32M |
|
|
HSTO
1850
DELISTED
Histogen Inc. Common Stock
HSTO
| $3.55M | 0.01% |
3,234
+342
| +12% | +$389K |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.